Definition and Characteristics

Assay for serum phosphate measures inorganic phosphates, mainly H2PO4 and HPO4 2− (85%). Hypophosphatemia is defined as the fasting serum level less than 2.5 mg/dl (0.80 mmol/l). Less than 1.0 mg/dl (0.32 mmol/l) is considered to be severe hypophosphatemia that requires rapid correction.

Acute, severe hypophosphatemia may result in dysfunction of the cells, such as hemolysis, impaired chemotaxis of leukocytes, platelet dysfunction, rhabdomyolysis, encephalopathy, and heart failure. Chronic hypophosphatemia may be manifested by anorexia, muscle pain, and rickets/osteomalacia [1].

Prevalence

Hypophosphatemia is encountered as low as 0.43% of hospitalized patients. Higher prevalence has been reported in patients with alcoholism (0.9%), sepsis (2.4%), malnutrition (10.4%), and diabetic ketoacidosis (14.6%).

Genes

Gene mutations have been identified in various diseases with hypophosphatemia, including X-linked hypophosphatemic rickets: XLH (PHEX gene...

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Chapter
EUR 29.95
Price includes VAT (Germany)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
EUR 1,069.99
Price includes VAT (Germany)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
EUR 1,283.99
Price includes VAT (Germany)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free ship** worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Amanzadeh J, Reilly RF Jr (2006) Hypophosphatemia: an evidence-based approach to its clinical consequences and management. Nat Clin Pract Nephrol 2:136–148

    PubMed  CAS  Google Scholar 

  2. Tennenhouse H, Murer H (2003) Disorders of renal tubular phosphate transport. J Am Soc Nephrol 14:240–247

    Google Scholar 

  3. Berndt TJ, Schiavi S, Kumar R (2005) “Phosphatonins” and the regulation of phosphorus homeostasis. Am J Physiol Renal Physiol 289:F1170–F1182

    PubMed  CAS  Google Scholar 

  4. Yu X, White KE (2005) FGF23 and disorders of phosphate homeostasis. Cytokine Growth Factor Rev 16:221–232

    PubMed  CAS  Google Scholar 

  5. Fukagawa M, Nii-Kono T, Kazama JJ (2005) Role FGF23 in health and in chronic kidney disease. Curr Opin Nephrol Hypertens 14:325–329

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2009 Springer-Verlag GmbH Berlin Heidelberg

About this entry

Cite this entry

Fukagawa, M., Tanaka, M. (2009). Hypophosphatemia. In: Lang, F. (eds) Encyclopedia of Molecular Mechanisms of Disease. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-29676-8_903

Download citation

Publish with us

Policies and ethics

Navigation